Lack of a significant effect of arctiin on development of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in ovariectomized Sprague-Dawley rats

Nutrition and Cancer

Volumn 57, Issue 2, 2007, Pages 201-208

  Hasumura, Mai ^a   Ueda, Makoto ^a   Onose, Jun Ichi ^a   Imai, Toshio ^a   Hirose, Masao ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; ARCTIIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER MODEL; CHEMICAL STRUCTURE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; NONHUMAN; OUTCOME ASSESSMENT; OVARIECTOMY; RAT; SOYBEAN; SPRAGUE DAWLEY RAT;

ANIMALIA; GLYCINE MAX; RATTUS;

EID: 34447529337     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635580701277585     Document Type: Article

References (44)

1. Heinonen S, Nurmi T, Liukkonen K, Poutanen K, Wahala K, et al.: In vitro metabolism of plant lignans: new precursors of mammalian lignans enterolactone and enterodiol. J Agri Food Chem 49, 3178-3186, 2001.
2. Bowey E, Adlercreutz H, and Rowland I: Metabolism of isoflavones and lignans by the gut microflora: a study in germ-free and human flora associated rats. Food Chem Toxicol 41, 631-636, 2003.
3. Lampe JW: Isoflavonoid and lignan phytoestrogens as dietary biomarkers. J Nutr 133, 956S-964S, 2003.
4. Sarkar FH and Li Y: The role of isoflavones in cancer chemoprevention. Front Biosci 9, 2714-2724, 2004.
5. Nose M, Fujimoto T, Takeda T, Nishibe S, and Ogihara Y: Structural transformation of lignan compounds in rat gastrointestinal tract. Planta Med 58, 520-523, 1992.
6. Nose M, Fujimoto T, Nishibe S, Ogihara Y: Structural transformation of lignan compounds in rat gastrointestinal tract. II. Serum concentration of lignans and their metabolites. Planta Med 59, 131-134, 1993.
7. Xie LH, Ahn EM, Akao T, Abdel-Hafez AA, Nakamura N, et al.: Transformation of arctiin to estrogenic and antiestrogenic substances by human intestinal bacteria. Chem Pharm Bull (Tokyo) 51, 378-384, 2003.
8. Adlercreutz H, Goldin BR, Gorbach SI, Hockerstedt KA, Watanabe S, et al.: Soybean phytoestrogen intake and cancer risk. J Nutr 125, 757S-770S, 1995.
9. Hirano T, Gotoh M, and Oka K: Natural flavonoids and lignans are potent cytostatic agents against human leukemic HL-60 cells. Life Sci 55, 1061-1069, 1994.
10. Huang DM, Guh JH, Chueh SC, and Teng CM: Modulation of anti-adhesion molecule MUC-1 is associated with arctiin-induced growth inhibition in PC-3 cells. Prostate 59, 260-267, 2004.
11. Nishibe S: Bioactive phenolic compounds for cancer prevention from herbal medicines In: Food Factors for Cancer Prevention, Ohigashi H, Osawa T, Terao J, Watanabe S, Yoshikawa T (eds.). Berlin: Springer, 1997, pp. 276-279.
12. Cho SH, Rhee SJ, Choi SW, and Choi Y: Effects of forsythia fruit extracts and lignan on lipid metabolism. Biofactors 22, 161-163, 2004.
13. Gotoh T, Yamada K, Yin H, Ito A, Kataoka T, et al.: Chemoprevention of N-nitroso-N-methylurea-induced rat mammary carcinogenesis by soy foods or biochanin A. Jpn J Cancer Res 89, 137-142, 1998.
14. Constantinou AI, Lantvit D, Hawthorne M, Xu X, van Breemen RB, et al.: Chemopreventive effects of soy protein and purified soy isoflavones on DMBA-induced mammary tumors in female Sprague-Dawley rats. Nutr Cancer 41, 75-81, 2001.
15. Constantinou AI, Mehta RG, Vaughan A: Inhibition of N-methyl-N- nitrosourea-induced mammary tumors in rats by the soybean isoflavones. Anticancer Res 16, 3293-3298, 1996.
16. Hirose M, Yamaguchi T, Lin C, Kimoto N, Futakuchi M, et al.: Effects of arctiin on PhIP-induced mammary, colon and pancreatic carcinogenesis in female Sprague-Dawley rats and MeIQx-induced hepatocarcinogenesis in male F344 rats. Cancer Lett 155, 79-88, 2000.
17. Kitamura Y, Yamagishi M, Okazaki K, Son HY, Imazawa T, et al.: Lack of significant inhibitory effects of a plant lignan tracheloside on 2-amino-1 -methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced mammary carcinogenesis in female Sprague-Dawley rats. Cancer Lett 200, 133-139, 2003.
18. Yamamoto S, Sobue T, Kobayashi M, Sasaki S, Tsugane S: Soy, isoflavones, and breast cancer risk in Japan. J Natl Cancer Inst 95, 906-913, 2003.
19. Lee MM, Gomez SL, Chang JS, Wey M, Wang RT, et al.: Soy and isoflavone consumption in relation to prostate cancer risk in China. Cancer Epidemiol Biomarkers Prev 12, 665-668, 2003.
20. Thompson LU, Chen JM, Li T, Strasser-Weippl K, and Goss PE: Dietary flaxseed alters tumor biological markers in postmenopausal breast cancer. Clin Cancer Res 11, 3828-3835, 2005.
21. Russo J, Gusterson BA, Rogers AE, Russo IH, Wellings SR, et al.: Comparative study of human and rat mammary tumorigenesis. Lab Invest 62, 244-278, 1990.
22. Nandi S, Guzman RC, Yang J: Hormones and mammary carcinogenesis in mice, rats, and humans: A unifying hypothesis. Proc Natl Acad Sci USA 92, 3650-3657, 1995.
23. Li S, Martel C, Dauvois S, Belanger A, and Labrie F: Effect of estrone on the growth of 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in the rat: a model of postmenopausal breast cancer. Endocrinology 134, 1352-1357, 1994.
24. Begum AN, Nicolle C, Mila I, Lapierre C, Nagano K, et al.: Dietary lignins are precursors of mammalian lignans in rats. J Nutr 134, 120-127, 2004.
25. Elledge RM, Green S, Pugh R, Allred DC, Clark GM, et al.: Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: a Southwest Oncology Group Study. Int J Cancer 89, 111-117, 2000.
26. Tanaka H, Hirose M, Kawabe M, Sano M, Takesada Y, et al.: Post-initiation inhibitory effects of green tea catechins on 7,12-dimethylbenz[a]anthracene- induced mammary gland carcinogenesis in female Sprague-Dawley rats. Cancer Lett 116, 47-52, 1997.
27. Hirose M, Mizoguchi Y, Yaono M, Tanaka H, Yamaguchi T, et al.: Effects of green tea catechins on the progression or late promotion stage of mammary gland carcinogenesis in female Sprague-Dawley rats pretreated with 7,12-dimethylbenz(a)anthracene. Cancer Lett 112, 141-147, 1997.
28. Cheng JL, Futakuchi M, Ogawa K, Iwata T, Kasai M, et al.: Dose response study of conjugated fatty acid derived from safflower oil on mammary and colon carcinogenesis pretreated with 7,12-dimethylbenz[a]anthracene (DMBA) and 1,2-dimethylhydrazine (DMH) in female Sprague-Dawley rats. Cancer Lett 196, 161-168, 2003.
29. Ip C and Scimeca JA: Conjugated linoleic acid and linoleic acid are distinctive modulators of mammary carcinogenesis. Nutr Cancer 27, 131-135, 1997.
30. Ueda M, Imai T, Takizawa T, Onodera H, Mitsumori K, et al.: Possible enhancing effects of atrazine on growth of 7,12-dimethylbenz(a) anthracene-induced mammary tumors in ovariectomized Sprague-Dawley rats. Cancer Sci 96, 19-25, 2005.
31. Thordarson G, Lee AV, McCarty M, Van Horn K, Chu O, et al.: Growth and characterization of N-methyl-N-nitrosourea-induced mammary tumors in intact and ovariectomized rats. Carcinogenesis 22, 2039-2047, 2001.
32. Cos S, Gonzalez A, Guezmes A, Mediavilla MD, Martinez-Campa C, et al.: Melatonin inhibits the growth of DMBA-induced mammary tumors by decreasing the local biosynthesis of estrogens through the modulation of aromatase activity. Int J Cancer 118, 274-278, 2006.
33. Ueda M, Takagi H, Onodera H, Yasuhara K, Takizawa T, et al.: Enhancing effects of beta-estradiol 3-benzoate but not methoxychlor on the promotion/progression stage of chemically-induced mammary carcinogenesis in ovariectomized rats. Jpn J Cancer Res 93, 752-759, 2002.
34. Pillow PC, Duphorne CM, Chang S, Contois JH, Strom SS, et al.: Development of a database for assessing dietary phytoestrogen intake. Nutr Cancer 33, 3-19, 1999.
35. Thompson LU, Rickard SE, Orcheson LJ, and Seidl MM: Flaxseed and its lignan and oil components reduce mammary tumor growth at a late stage of carcinogenesis. Carcinogenesis 17, 1373-1376, 1996.
36. Rickard SE, Yuan YV, Chen J, and Thompson LU: Dose effects of flaxseed and its lignan on N-methyl-N-nitrosourea-induced mammary tumorigenesis in rats. Nutr Cancer 35, 50-57, 1999.
37. Saarinen NM, Warri A, Makela SI, Eckerman C, Reunanen M, et al.: A novel enterolactone precursor with antitumor properties from coniferous tree (Picea abies). Nutr Cancer 36, 207-216, 2000.
38. Saarinen NM, Huovinen R, Warri A, Makela SI, Valentin-Blasini L, et al.: Uptake and metabolism of hydroxymatairesinol in relation to its anticarcinogenicity in DMBA-induced rat mammary carcinoma model. Nutr Cancer 41, 82-90, 2001.
39. Wang LQ: Mammalian phytoestrogens: enterodiol and enterolactone. J Chromatogr B Analyt Technol Biomed Life Sci 777, 289-309, 2002.
40. Martin ME, Haourigui M, Pelissero C, Benassayag C, and Nunez EA: Interactions between phytoestrogens and human sex steroid binding protein. Life Sci 58, 429-436, 1996.
41. Saarinen NM, Huovinen R, Warri A, Makela SI, Valentin-Blasini L, et al.: Enterolactone inhibits the growth of 7,12-dimethylbenz(a)anthracene-induced mammary carcinomas in the rat. Mol Cancer Ther 1, 869-876, 2002.
42. Ingram D, Sanders K, Kolybaba M, and Lopez D: Case-control study of phyto-oestrogens and breast cancer. Lancet 350, 990-994, 1997.
43. Adlercreutz H, Fotsis T, Heikkinen R, Dwyer JT, Woods M, et al.: Excretion of the lignans enterolactone and enterodiol and of equol in omnivorous and vegetarian postmenopausal women and in women with breast cancer. Lancet 2, 1295-1299,1982.
44. Boylan ES, Fowler EH, and Wittliff JL: Morphology, growth characteristics and oestrogen-binding capacity of DMBA-induced mammary tumours from ovariectomized rats. Br J Cancer 35, 602-609, 1977